Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Ursula Pertl

Title(s)Associate Physician, Pediatrics
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med. 2002 Dec; 8(12):1369-75. Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceiri BP, Reisfeld RA. PMID: 12415261.
      View in: PubMed   Mentions: 118     Fields:    Translation:AnimalsCellsPHPublic Health
    2. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood. 2003 Jan 15; 101(2):649-54. Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA. PMID: 12393580.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    3. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Res. 2001 Dec 01; 61(23):8498-503. Ruehlmann JM, Xiang R, Niethammer AG, Ba Y, Pertl U, Dolman CS, Gillies SD, Reisfeld RA. PMID: 11731434.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    4. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy. Proc Natl Acad Sci U S A. 2001 Jun 19; 98(13):7528-33. Shabat D, Lode HN, Pertl U, Reisfeld RA, Rader C, Lerner RA, Barbas CF. PMID: 11404472; PMCID: PMC34702.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    5. IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol. 2001 Jun 01; 166(11):6944-51. Pertl U, Luster AD, Varki NM, Homann D, Gaedicke G, Reisfeld RA, Lode HN. PMID: 11359856.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    6. Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice. Clin Cancer Res. 2001 Mar; 7(3 Suppl):856s-864s. Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA. PMID: 11300483.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    7. Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma. Med Pediatr Oncol. 2000 Dec; 35(6):641-6. Lode HN, Pertl U, Xiang R, Gaedicke G, Reisfeld RA. PMID: 11107137.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    8. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proc Natl Acad Sci U S A. 2000 Oct 10; 97(21):11500-4. Balicki D, Reisfeld RA, Pertl U, Beutler E, Lode HN. PMID: 11016973; PMCID: PMC17229.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    9. Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction. J Clin Invest. 2000 Jun; 105(11):1623-30. Lode HN, Xiang R, Pertl U, Förster E, Schoenberger SP, Gillies SD, Reisfeld RA. PMID: 10841521; PMCID: PMC300854.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    10. What to do with targeted IL-2. Drugs Today (Barc). 2000 May; 36(5):321-36. Lode HN, Xiang R, Perri P, Pertl U, Lode A, Gillies SD, Reisfeld RA. PMID: 12861355.
      View in: PubMed   Mentions: 2     Fields:    
    Ursula's Networks
    Concepts (82)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California